Investors
Latest News
23 Jul 2025
AD HOC
Cosmo Delivers Strong Performance in H1 2025, Raises Full-Year EBITDA Guidance and Accelerates Recurring Revenue Growth Across AI and Dermatology
Read More17 Jul 2025
Cosmo announces launch of Winlevi® for Treatment of Acne in Singapore and Malaysia
Read More16 Jul 2025
Cosmo Accelerates Global ESG Leadership with Major Ratings Upgrades, UN Compact Commitment, and Climate Action Pledge
Read MoreUpcoming Events
Share price
More informationsManufacturing
We provide services related to the production of pharmaceutical products as: assessment of manufacturing processes, technology transfer, evaluation of pharmaceutical product stability, testing and release to the market and drafting of the necessary documentation for pharmaceutical products’ registration.
Find out more